Patents by Inventor Miguel N. Rivera

Miguel N. Rivera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE
    Publication number: 20230302035
    Abstract: Methods for predicting response to immunotherapy and selecting immunotherapy for treating cancer, e.g., cancer of epithelial origin, in a subject.
    Type: Application
    Filed: January 19, 2023
    Publication date: September 28, 2023
    Inventors: David T. Ting, Miguel N. Rivera, Vikram Deshpande, Kshitij Arora, Benjamin Dylan Greenbaum, Alexander V. Solovyov
  • METHODS FOR DETECTING NTRK GENE FUSION USING RNA IN SITU HYBRIDIZATION
    Publication number: 20230088452
    Abstract: A method of detecting a neurotrophic tyrosine receptor kinase (NTRK) fusion gene, comprising obtaining a sample and detecting a NTRK fusion gene in the sample by RNA in situ hybridization using a probe comprising a nucleic acid sequence complementary to a region of mRNA encoding a kinase domain of NTRK1, NTRK2, or NTRK3.
    Type: Application
    Filed: February 24, 2021
    Publication date: March 23, 2023
    Inventors: Xiao-Jun Ma, Robert J. Monroe, David T. Ting, Miguel N. Rivera, Vikram Deshpande, Azfar Neyaz, Baris Boyraz
  • REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE
    Publication number: 20210213041
    Abstract: Methods for predicting response to immunotherapy and selecting immunotherapy for treating cancer, e.g., cancer of epithelial origin, in a subject.
    Type: Application
    Filed: February 6, 2019
    Publication date: July 15, 2021
    Inventors: David T. Ting, Miguel N. Rivera, Vikram Deshpande, Kshitij Arora, Benjamin Dylan Greenbaum, Alexander V. Solovyov